FDA advisers vote against OTC Pravachol.
Walczak
I M
IM
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004032:Diet; D005260:Female; D006266:Health Education; D006801:Humans; D008019:Life Style; D008297:Male; D004366:Nonprescription Drugs / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D004366:Nonprescription Drugs; D002784:Cholesterol; D017035:Pravastatin